Hypertrust Mentioned in All Four Gartner Hype Cycle Reports 2023

Munich (DE) – In a significant recognition of our commitment to innovation and excellence, Hypertrust has been now featured in all four relevant Gartner Hype Cycle Reports for 2023. The reports, which encompass various facets of the life sciences industry, include:

1. Hype Cycle for Life Science Discovery Research, 2023
2. Hype Cycle for Life Science Clinical Development, 2023
3. Hype Cycle for Life Science Commercial Operations, 2023
4. Hype Cycle for Life Science Manufacturing, Quality and Supply Chain, 2023

This mentioning as a Cell & Gene Therapy Orchestration Platform Vendor emphasizes Hypertrust’s central role in transforming and advancing the life sciences landscape. Gartner, a globally recognized authority in technology research and advisory services, has highlighted Hypertrust’s solutions across multiple crucial stages of the life sciences ecosystem.

Key Highlights from the Gartner Hype Cycle Reports:

1. Life Science Discovery Research, 2023: Hypertrust’s innovative solutions are recognized for their contribution to revolutionizing the discovery phase, providing critical support and technologies that accelerate breakthroughs in life science research.

2. Life Science Clinical Development, 2023: In the realm of clinical development, Hypertrust stands out for its cutting-edge technologies that streamline processes, enhance collaboration, and bring efficiency to the complex landscape of clinical trials.

3. Life Science Commercial Operations, 2023: Gartner acknowledges Hypertrust’s significant impact on commercial operations within the life sciences sector. The company’s solutions play a vital role in optimizing sales, marketing, and other key business functions.

4. Life Science Manufacturing, Quality, and Supply Chain, 2023: Hypertrust’s presence is highlighted in the critical domains of manufacturing, quality, and supply chain management. The company’s innovative technologies are instrumental in ensuring the highest standards in production and delivery within the life sciences manufacturing sector.

Note: Gartner does not endorse any vendor, product, or service depicted in its research publications.